Thomas Breuer and colleagues at GlaxoSmithKline respond to Peter Doshi

BMJ. 2018 Oct 3:363:k4116. doi: 10.1136/bmj.k4116.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Influenza Vaccines*
  • Influenza, Human / prevention & control
  • Information Dissemination
  • Patient Safety

Substances

  • Influenza Vaccines
  • pandemrix